RE: Impressed25 Jan 2024 21:53
Https://m.youtube.com/watch?v=ZqhxdcPgjHw
I was reviewing old stuff from MHCs updates and investor meetings etc.
This one last year was so interesting for many reasons.
The fact it proceeded a time when the first six months had seen such low revenue and MHC was streaming the costs to ensure they had sufficient cash reserves.
Since then they have had a further 7 months of solid sales bringing in huge revenue streams.
Back to to investors meeting.
1, I note our Chairman stated they would be putting out forward sales projections for the new products by end of year or next year meaning early 2024.
So I hope he’s in a position to update us shortly!.
2, Penny was extremely confident in phlebotomy department and almost emphasised the fact that they were trialing things that need to be financially beneficial to the NHS. The fact she also almost certainly eluded to Boots in store testing facility and the digital data along with the WIH achievement gives me 100% confidence that we should expect Ann announcement that certain Tests will be available to NHS referred patients direct to Boots Hubs.
I would say given the increased revenue from June last year this has been essential to driving to expansion more rapidly.
3, Penny also ruled out acquisitions but focused on partnerships. She also said the wellbeing market will see smaller companies fail or get adsorbed!.
4, I wonder if the board are aware of price sensitive information which may be why they haven’t purchased cheap stock. Adam did say whilst they had cash acquisitions would usually be funded by a higher share price to raise equity so they clearly would have no interest unless price rose significantly.
5, it’s clear the new products are being sold more each day but they also mentioned the 801 stores selling tests in store. Would be interesting to note if these stores also have the boots in store testing facilities.
I believe the answer would be yes.
I think given Adam Reynolds comments we should assume a RNS with guidance on new tests be published to the market to ensure credibility is in tact. This could be a game changer.
I also believe they are selling off the 5pks to ensure old stock is sold before bringing in new 25pks.
I think the share price needs these figures before we see a significant run up on the price. Until then we may just range trade so I hope it soon as nearly 9 months data available on new tests sales.
Sign In
Follow the stocks
